09:04 AM EDT, 07/19/2024 (MT Newswires) -- Health care stocks were mixed pre-bell Friday as the Health Care Select Sector SPDR Fund ( XLV ) was up 0.6% and the iShares Biotechnology ETF ( IBB ) was recently flat.

Augmedix ( AUGX ) rallied past 147% after the company said it has agreed to be acquired by Commure in an all-cash deal valued at about $139 million.

Eli Lilly's ( LLY ) Mounjaro received approval from China's National Medical Products Administration for long-term weight management, Bloomberg reported, citing a company statement on Eli Lilly's ( LLY ) official WeChat account. Eli Lilly ( LLY ) was up more than 2% premarket.

Agenus ( AGEN ) fell by over 5%, still declining after it announced Thursday that the US Food and Drug Administration discouraged an accelerated approval pathway for its potential colorectal cancer combination treatment consisting of botensilimab and balstilimab.